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Pregestational diabetes is associated with fetal macrosomia, and umbilical perfusion of the
fetal liver has a role in regulating fetal growth. We therefore hypothesized that pregestational
diabetes alters fetal liver blood flow depending on degree of glycemic control.
Methods
In a prospective study, 49 women with pregestational diabetes underwent monthly ultra-
sound examinations during 24–36 gestational weeks. Blood flow was determined in the
umbilical vein, ductus venosus and portal vein, and blood velocity was measured in the left
portal vein, the latter reflecting the watershed between splanchnic and umbilical flow. The
measurements were compared with reference values by z-score statistics, and the effect of
HbA1c assessed.
Results
The umbilical venous flow to the liver (z-score 0.36, p = 0.002), total venous liver flow (z-
score 0.51, p<0.001) and left portal vein blood velocity (z-score 0.64, p<0.001), were higher
in the study group. Normalized portal venous flow was lower (z-score -0.42, p = 0.002), and
normalized total venous liver flow tended to be lower after 30 gestational weeks (z-score
-0.54, p = 0.047) in the diabetic pregnancies compared with reference values from a low-risk
population. The left portal vein blood velocity was positively, and the portal fraction of total
venous liver flow negatively correlated with first trimester HbA1C.
Conclusions
In spite of increased umbilical blood distribution to the fetal liver, graded according to glyce-
mic control, the total venous liver flow did not match third trimester fetal growth in pregnan-
cies with pregestational diabetes, thus contributing towards increased perinatal risks and
possibly altered liver function with long-term metabolic consequences.
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Introduction
Pregnancies complicated by pregestational diabetes mellitus (PGDM) are associated with
increased perinatal morbidity and mortality [1], and fetal macrosomia is related to these
adverse neonatal outcomes [2]. Fetal hyperglycemia and hyperinsulinemia can cause acceler-
ated fetal growth [3] even with HbA1C levels within the recommended range [4], and this
makes clinical surveillance in diabetic pregnancies challenging [5].
The liver has been called “the metabolic brain” of the fetus [6], controlling the distribution
and utilization of nutrients from the placenta. Nutrient access and fetal liver blood flow act
both independently and together to influence fetal growth and body composition [7, 8]. The
fetal liver has two sources of venous supply; well-oxygenated blood from the placenta through
the umbilical vein being the main source, and low-oxygenated blood from visceral organs
through the portal vein. The distribution of the nutrient rich umbilical venous blood to the
liver has been suggested to be a mechanism for regulation of fetal growth [9]. This is based on
experimental studies showing that increasing liver flow from the umbilical vein leads to higher
cell proliferation in the liver, heart, skeletal muscle and kidneys in fetal lamb [9]. In addition,
studies of human low-risk pregnancies have shown that larger fetal size is associated with
higher umbilical venous liver flow as a response to maternal glucose intake [10]. Also, higher
umbilical venous flow to the liver is associated with newborn adiposity [11].
In studies of macrosomic fetuses in non-diabetic pregnancies, umbilical- and total venous
liver flow was higher during the 2nd and 3rd trimester, including when normalized for esti-
mated fetal weight [7, 12]. This indicates that increased umbilical venous flow led to aug-
mented fetal growth in pregnancies without diabetes. In low-risk pregnancies, the portal
venous contribution to the liver increases throughout gestation, and the same pattern is
observed in macrosomic non-diabetic fetuses [7]. However, although the fetal liver is larger
[13] and macrosomic growth is frequent in diabetic pregnancies [4], umbilical venous flow
normalized for fetal weight, is lower [13, 14].
Fetal liver gene expression in baboons is different in the left and right liver lobes [15], and
this is ascribed to the specific venous perfusion pattern during fetal life. Thus, fetal hemody-
namic development might influence liver function and be part of a pathway regulating intra-
uterine growth, with possible long-term consequences [7, 12].
In diabetic pregnancies, fetal liver size measured by ultrasound is greater than in low-risk
pregnancies and liver volume positively correlates with maternal HbA1C [13]. Experimental
studies in pigs showed that diabetes induces fetal liver hyperplasia [16], the fetal liver protein
synthesis and glycogen reserves increase [16], and total body fat percentage is higher than in
non-diabetic controls [17]. In human stillborn neonates of diabetic mothers, hepatic steatosis
is prevalent and more severe than in stillborn of non-diabetic pregnancies [18].
Fetuses of women with PGDM have greater risk of later diabetes independently of genetic
factors [19], possibly mediated through epigenetic mechanisms. It has been suggested that the
human fetal strategy to prioritize fat deposition for neonatal survival evolved under conditions
where high glycemic diets were not available; but with their currently widespread consump-
tion, these mechanisms enhance fetal fat deposition [20]. As both diabetes [21] and chronic
liver disease [22] are becoming increasingly prevalent, and there is currently much interest in
the developmental origins of these conditions, studies of factors such as maternal diabetes on
fetal liver development are called for as a basis for informing preventive strategies [23]. We
therefore aimed to determine the fetal liver blood flow in PGDM pregnancies in a prospective
longitudinal study and present the longitudinal development of venous liver blood flow during
the second half of PGDM pregnancies.
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Materials and methods
The present prospective longitudinal observational study is part of a larger project investigat-
ing fetal hemodynamics in pregnancies with PGDM. The study protocol was approved by the
Regional Committee for Medical and Health Research Ethics (REK vest 2011/2030). We have
reported the development of the umbilical venous and ductus venosus flows in this population
[14]. Here we present data on the development of the venous supply to the fetal liver in PGDM
pregnancies. We have used the left portal vein blood velocity as a marker of the watershed
between the portal and umbilical venous contributions (Fig 1).
Subjects
All women in our region, with PGDM in pregnancy, are referred to our tertiary center at Hau-
keland University Hospital for multidisciplinary follow-up. All women with singleton preg-
nancies and PGDM who presented at our clinic between August 2013 and May 2016 were
invited to participate. Fifty-two women (74% of those invited) gave written consent: 44 partici-
pants had type 1 diabetes mellitus (DM) and 8 had type 2 DM of which all received gestational
insulin treatment. Three participants with type 2 DM withdrew, leaving a total of 49 PGDM
pregnancies for statistical analyzes. Gestational age (GA) was determined using a vaginal
probe (Vivid 7, GE Healthcare Vingmed Ultrasound, E8C, 8 MHz) at the first visit (around
week 9), by measuring the crown rump length [24]. No fetal malformations were revealed by
Fig 1. Venous supply to the fetal liver. Cross section of the fetal abdomen with black arrows indicating physiological
blood flow directions in the fetal liver (grey). Typically, well-oxygenated umbilical blood (red) blends in with
deoxygenated portal blood (blue) to feed the right liver lobe; UV, umbilical vein; DV, ductus venosus; LPV, Left portal
vein; PV, portal vein; S, spine; V, stomach.
https://doi.org/10.1371/journal.pone.0211788.g001
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second-trimester routine scans in the study population. Information on first trimester mater-
nal HbA1C, neonatal sex, birthweight, mode of delivery, Apgar score, cord-blood gases, and
transfer to the neonatal ward was collected from clinical records. The results from the study
group were compared with reference ranges established in the same research unit using identi-
cal methods, in a longitudinal study of 160 low-risk pregnancies [25, 26].
Measurements
The ultrasound examinations were performed in each pregnancy at gestational weeks 24, 28,
32, and 36. All ultrasound measurements were performed by three observers (A.L., J.K. and C.
E.) using an abdominal transducer (M4S, 2.0–4.3 MHz) ultrasound system (Vivid 7, GE
Healthcare Vingmed Ultrasound, Horten, Norway). The sessions lasted maximum one hour
and the thermal index was kept below 1.0.
The time-averaged maximum blood velocity (TAMXV) was measured in the umbilical
vein, ductus venosus, left portal vein and portal vein (Fig 1). The angle of insonation was kept
small, not exceeding 30˚ (median angle correction was 0, range 0–30˚). At the same site per-
pendicular to the vessel wall, the inner vessel diameter (D) was measured at least three times in
the umbilical vein, ductus venosus and portal vein. The mean D was used for the analyses (Fig
1). After identification of the vessel, the color Doppler was turned off and D was measured in
magnified images. The techniques applied are described in detail elsewhere [25, 26].
Blood flow (Q, mL�min–1) was calculated by the formula Q = π � (D/2)2 � h � TAMXV. The
velocity profile parameter was h = 0.5 for the umbilical vein (UV) and the portal vein (PV)
[26], h = 0.7 for the ductus venosus (DV) [27, 28]. Flow was normalized based on the estimated
fetal weight (EFW) as Q/EFW (mL�min–1�kg–1) [29]. Umbilical venous liver flow (UVliver) was
calculated as QUV liver = QUV −QDV, total liver flow as Qliver = (QUV −QDV) + QPV and PV frac-
tion (FPV) of the total venous supply to the liver was FPV = 100% � QPV/Qliver.
Statistics
The sample size was based on our previous studies in non-diabetic pregnancies, demonstrating
significant associations between fetal growth patterns and variation in the venous liver circula-
tion [7, 30]. We allowed for lower measurement success rates and possibly smaller effects in
the PGDM group by increasing the number of participants from 30 to 50. It was not possible
to perform a formal sample size calculation since there were no earlier reports on the effects of
PGDM on fetal liver flow.
Multilevel regression analysis was used to model the mean and standard deviation values
for the outcome variables according to gestational age. The absence of overlap of the 95% con-
fidence intervals of the mean indicated a statistically significant difference between the PGDM
group and the reference values [25, 26, 31]. In addition, z-scores for means of outcome vari-
ables in the study population were compared with the reference group using the independent-
samples t-test, with a significance cutoff of p�0.05. The populations were also stratified for ges-
tational age (GA</� 30 weeks), and independent sample t-tests comparing mean z-scores
were performed to test differences between PGDM and low-risk pregnancies before and after
30 weeks of gestation. The relations between maternal first-trimester HbA1c and left portal
vein flow velocity, portal venous flow, and portal venous shunt fraction z-scores after 30 gesta-
tional weeks were assessed using multilevel regression analysis. The statistical analyses were
performed with the Statistical Package for the Social Sciences (version 24, SPSS, Chicago, IL)
and the MLWin program (version 2.35, Centre of Multilevel Modeling, University of Bristol,
UK).
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Results
The characteristics of the study population are described in Tables 1 and 2. The median gesta-
tional age at birth was lower and birthweights were higher in the study group than in the refer-
ence population [31]. In the study group, 19 (39%) of the neonates were macrosomic
(birthweight >90th percentile) and 3 (6%) were small for gestational age (<10th percentile)
[29] (Tables 1 and 2).
The left portal vein and portal vein blood velocity, and the portal vein diameters, were suc-
cessfully measured in 94.4%, 70.9% and 55.9% of 179 examination sessions, respectively. Fur-
ther, portal venous flow was calculated in 52.5%, total venous liver flow (Qliver) in 42.5%, and
the portal venous fraction of the total venous liver flow in 42.5% of the sessions. The success
rate for the umbilical vein and ductus venosus measurements have been published earlier [14].
The mean left portal vein flow velocity in the PGDM group was significantly higher than
the reference values, both before and after 30 weeks (Table 3, Fig 2A).
The mean portal venous flow in the PGDM pregnancies was not significantly different
from the reference values over the study period as a whole, but was significantly higher for the
period before 30 weeks of gestation, and the development after 30 weeks was blunted com-
pared with the reference values (Fig 3A). When normalized for EFW, the overall mean portal
venous flow was significantly smaller in PGDM, mainly due to reduced flow after 30 weeks of
gestation (Table 3 and Fig 3B).
Table 1. Maternal characteristics and outcomes in 49 pregnancies with pregestational diabetes mellitus.
Number Percent
Type 1 DM 44 89.8
Type 2 DM 5 10.2
Maternal diabetic complications or condition
- Retinopathy 9 18.4
- Nephropathy 1 2.0
- Hypothyroidism 9 18.4
- Chronic hypertension 7 14.3
Preeclampsia 3 6.1
Preterm birth 15 30.6
Induction of labor 30 61.2
Normal delivery 20 40.8
Operative vaginal delivery 7 14.3
Cesarean section 22 44.9
- Elective 9 18.4
- Acute 13 26.5
Median Range
Maternal age (years) 31 23 to 42
Pre-pregnancy weight (kg) 70 57 to 113
Maternal weight gain 15.8 -5.0 to 33.1
Pre-pregnancy BMI 24.9 19.8 to 44.1
HbA1c at inclusion (%) 6.7 4.9 to 12.0
Individual mean HbA1c† (%) 6.12 4.9 to 8.2
DM, diabetes mellitus; Preterm birth, gestational age <37 weeks
�acute cesarean section during labor
†mean of all HbA1c measurements throughout each pregnancy
https://doi.org/10.1371/journal.pone.0211788.t001
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The total venous supply to the fetal liver (Qliver) was larger in PGDM pregnancies (Table 3),
mainly due to high volumes in the second trimester (Fig 4A). When normalized for EFW, the
overall mean total venous liver flow in the PGDM group did not differ from that of the refer-
ence values but was significantly smaller after 30 weeks and with a different trajectory of the
mean curve (Table 3 and Fig 4B).
In the study group, the mean portal venous fraction for all observations through pregnancy
did not differ from the low-risk group (Table 3). However, the curve describing mean portal
venous fraction had an inverted U-shape in PGDM fetuses, the opposite of that in the refer-
ence group, where the portal venous fraction increased after week 33 (Fig 2B).
The overall mean umbilical venous liver flow (Q UV liver) was higher in PGDM pregnancies
compared with the reference, mainly due to the high flows before 30 weeks of gestation (Fig
5A). However, when normalized for EFW, the overall mean umbilical venous liver flow was
not different from low-risk pregnancies (Table 3), but the trajectory of the flow development
tended to be different in PGDM pregnancies with borderline significantly lower flow after 30
weeks (Table 3, Fig 5B).
The z-scores for left portal vein blood velocity were positively related to first trimester
HbA1C and correspondingly, the z-scores for portal venous fraction were negatively related to
Table 2. Neonatal characteristics and outcomes in pregnancies with pregestational diabetes mellitus.
Median Range
Gestational age at delivery (weeks+days) 38+4 27+6 to 40+5
Birthweight (g) 3695 990 to 5990
Birthweight z-score 0.93 –2.15 to 5.82
Umbilical artery
- pH 7.24 6.92 to 7.34
- pCO2 (kPa) 7.88 5.80 to 12.40
- pO2 (kPa) 2.19 1.16 to 3.47
- Base deficit (mmol�L–1) –2.11 –13.36 to 1.00
- Lactate (mmol�L–1) 4.70 2.00 to 14.40
Umbilical vein
- pH 7.30 6.89 to 7.44
- pCO2 (kPa) 6.10 4.20 to 15.30
- pO2 (kPa) 3.29 0.25 to 5.68
- Base deficit (mmol�L–1) –2.36 –10.98 to –0.15
- Lactate (mmol�L–1) 3.50 1.80 to 12.80
Erythrocyte volume fraction 0.63 0.52 to 0.76
Number Percent
Male sex 25 51%
Operative delivery for intrapartum fetal distress 13 26.5%
Metabolic acidosis at birth� 1 2%
5-min Apgar score <7 1 2%
Neonatal intensive care 20 40.8%
Perinatal death† 1 2%
Malformation‡ 2 4%
� Metabolic acidosis defined as an umbilical arterial pH of <7.0 and a base deficit of >12.
† Intrauterine fetal death at gestational week 36. Autopsy showed UV thrombosis and signs of acute asphyxia.
‡ One neonate with sagittal craniosynostosis and one with congenital heart defect (anomalous left coronary artery
from the pulmonary artery)
https://doi.org/10.1371/journal.pone.0211788.t002
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first trimester HbA1C (Fig 6). There was no relation between HbA1C and portal venous or total
venous liver flow.
Since 39% of the neonates in our PGDM group were macrosomic, we compared the devel-
opment of the total venous liver, umbilical and portal flows in low-risk, non-diabetic macroso-
mic and PGDM pregnancies, to illustrate the different flow patterns (Fig 7).
We compared the mean z-scores in the T1DM group with the reference values for LPV
velocity, PV flow, normalized PV flow, total venous liver flow, normalized venous liver flow
and UV liver flow (S1 Table). Excluding T2DM participants from the PGDM population did
not significantly change the results, except for PV flow which then became borderline signifi-
cantly higher compared with the reference values (p = 0.046).
Table 3. Fetal venous liver blood flow in pregnancies complicated by pregestational diabetes mellitus compared with reference values from a low risk population.
Parameter Popu-lation n Mean z-score p GA <30 Mean z-score GA<30p GA�30 Mean z-score GA�30p
(95% CI) (95% CI) (95% CI)
LPV velocity (cm/s) Ref. 537 0.003 <0.001 0.011 <0.001 -0.005 <0.001
(-0.09–0.09) (-0.11–0.13) (-0.12–0.12)
PGDM 201 0.639 0.675 0.575
(0.49–0.79) (0.46–0.89) (0.29–0.86)
PV flow (mL�min–1) Ref. 547 0.011 0.052 0.016 0.005 0.006 0.131
(-0.09–0.11) (-0.10–0.13) (-0.12–0.13)
PGDM 93 0.272 0.796 -0.466
(0.03–0.52) (0.26–1.32) (-1.07–0.14)
Normalized PV flow (mL�min-1�kg-1) Ref. 547 0.007 0.002 0.022) 0.821 0.009 0.002
(-0.10–0.11) (-0.09–0.13 (-0.14–0.12)
PGDM 93 -0.418 0.089 -1.132
(-0.67 - -0.17) (-0.49–0.67) (-1.80 - -0.46)
Total venous liver flow, Qliver (mL�min
–1) Ref. 514 -0.005 <0.001 -0.008) 0.001 -0.001 0.881
(-0.10–0.09) (-0.13–0.11 (-0.13–0.13)
PGDM 75 0.507 0.847 -0.045
(0.26–0.75) (0.39–1.30) (-0.63–0.54)
Normalizedvenous liver flow (mL�min–1�kg–1) Ref. 473 0.010 0.479 0.007 0.342 0.033 0.047
(-0.09–0.11) (-0.13–0.11) (-0.11–0.17)
PGDM 75 -0.085 0.195 -0.538
(-0.33–0.16) (-0.21–0.60) (-1.08–0.01)
PV fraction of total venous liver flow (%) Ref. 511 0.004 0.645 -0.002 0.909 0.012 0.550
(-0.09–0.10) (-0.12–0.11) (-0.12–0.14)
PGDM 75 -0.098 0.028 0.217
(-0.35–0.16) (-0.49–0.54) (-0.46–0.89)
UV liver flow, QUV liver (mL�min
–1) Ref. 558 0.00 0.002 -0.02 <0.001 0.01) 0.952
(-0.09–0.10) (-0.13–0.09) (-0.11–0.14
PGDM 122 0.364 0.65 0.00
(0.16–0.57) (0.23–1.06) (-0.37–0.38)
Normalized UV liver flow (mL�min–1�kg–1) Ref. 558 0.004 0.229 -0.05 0.630 0.03) 0.049
(-0.09 –-0.10) (-0.17–0.07) (-0.09–0.15
PGDM 122 -0.131 0.03 -0.33
(-0.33–0.06) (-0.35–0.41) (-0.67–0.00)
PGDM, pregestational diabetes mellitus; Ref., low-risk reference group [25, 26]; n, number of observations; CI, confidence interval for the mean z-score; p, probability
value; GA, gestational age (weeks)—before and after 30 weeks; LPV, Left portal vein; PV, portal vein; Qliver, total venous liver flow; PV fraction (%) = (PV flow/Total
liver flow)�100; Q UV liver, umbilical venous flow to the liver
https://doi.org/10.1371/journal.pone.0211788.t003
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Fig 2. Longitudinal observations of left portal vein blood velocity and portal venous fraction in PGDM and low-risk pregnancies. Left portal vein blood velocity
(TAMXV) as marker of the watershed between portal and umbilical contribution to fetal venous liver flow (a), and the portal fraction (%) of total venous volume (b) in
49 pregnancies with pregestational diabetes (PGDM; red circles and lines) compared with reference values from a low-risk population (black lines) presented with mean
(thick lines) and 95% confidence interval (thin lines).
https://doi.org/10.1371/journal.pone.0211788.g002
Fig 3. Longitudinal observations of portal venous flow in PGDM and low-risk pregnancies. Portal venous flow (a) and normalized portal venous flow (b) in 49
pregnancies with pregestational diabetes (PGDM; red circles and lines) compared with reference values from a low-risk population (black lines), with mean (thick lines)
and 95% confidence-interval (thin lines).
https://doi.org/10.1371/journal.pone.0211788.g003
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Discussion
In pregnancies complicated with PGDM, the fetal liver perfusion with nutritious umbilical
blood from the placenta was prioritized (Table 3, Figs 1 and 2A). This effect was graded
according to the maternal HbA1c level (Fig 6) and was associated with correspondingly accel-
erated fetal growth during the 2nd trimester. However, the blunted umbilical flow development
Fig 4. Longitudinal observations of total venous supply to the fetal liver in PGDM and low-risk pregnancies. Total venous liver flow (a) and the
correspondingly normalized flow values (b) in 49 pregnancies with pregestational diabetes mellitus (PGDM; red circles and lines) compared with reference
values from a low-risk population (black lines) presented with mean (thick lines) and 95% confidence interval (thin lines).
https://doi.org/10.1371/journal.pone.0211788.g004
Fig 5. Longitudinal observations of the umbilical venous supply to the fetal liver in PGDM and low-risk pregnancies. Umbilical venous liver flow (a) and
the correspondingly normalized flow values (b) in 49 pregnancies with pregestational diabetes mellitus (PGDM; red circles and lines) compared with reference
values from a low-risk population (black lines) presented with mean (thick lines) and 95% confidence interval (thin lines).
https://doi.org/10.1371/journal.pone.0211788.g005
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during the 3rd trimester seemed to cause an increasing mismatch between growth and blood
supply (Table 3, Figs 2–5).
The venous supply to the liver is radically different in fetal and postnatal life, with contribu-
tions from both the umbilical (�80%) and the portal vein (�20%) (Figs 1 and 7) [26]. Thus,
the umbilical vein is the principal source of fetal liver blood supply [31], and this umbilical
venous flow to the liver is augmented in diabetic pregnancies (Table 3, Fig 5A). Such increased
delivery of oxygen and nutrient rich umbilical venous blood to the liver, is thought to be
instrumental in the development of macrosomia [8].
The left portal vein connects the umbilical vein with the portal circulation and directs
umbilical venous blood to the right lobe of the liver (Fig 1). Blood flow in the left portal vein is
regulated by catecholamines [32] and maternal glucose levels [10]. Measurement of the left
portal vein velocity alone provides a simple method for gauging the umbilical/portal watershed
and for assessment of intrahepatic venous redistribution in compromised fetuses [25]. In the
present study, the mean left portal vein velocity was higher in PGDM pregnancies than the ref-
erence values, throughout the second half of pregnancy (Fig 2A). This signifies increased prior-
itization of umbilical blood flow to the right liver lobe and is known to induce liver growth,
increased production of IGF-1 and -2 and in turn, differential organ growth [8, 9].
The portal contribution to the venous liver perfusion was higher in PGDM than the refer-
ence group before 30 weeks (Table 3), but the portal venous flow did not keep up with fetal
Fig 6. Fetal liver blood flow and relation to HbA1C. Relations between z-scores of the time-averaged maximum left portal vein (LPV)
flow velocity (TAMXV) and portal vein (PV) fraction, and first-trimester HbA1c.
https://doi.org/10.1371/journal.pone.0211788.g006
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growth later in pregnancy (Fig 3B). This corroborates a study of Olofsson et al., showing that
blood flow to the lower extremities was prioritized at the expense of visceral blood flow during
the third trimester, in pregnancies with type 1 DM [33]. In addition, lower portal venous
return could be a result of reduced fetal swallowing or intestinal activity in diabetic pregnan-
cies [34]. We hypothesize that the increased umbilical venous flow to the right liver lobe
observed in our study, may induce accelerated fetal growth that is less supported by umbilical
venous supply at the end of pregnancy, and without any increase of portal blood flow to the
liver. Higher umbilical venous flow to the right liver lobe, as found in our study, could also
influence liver gene expression [15], fetal body composition [11] and possibly later health [20].
In the present study, 39% of the newborns had a birthweight > 90th percentile for gesta-
tional age (Table 2). Fetal macrosomia in PGDM is different from that in non-diabetic preg-
nancies, with disproportionate fetal growth expressed as a higher ponderal index [35]. In a
study of macrosomic fetuses without maternal diabetes, the umbilical venous perfusion [12],
left portal venous flow, portal and total venous liver flow, were all increased during the second
half of pregnancy [7], even when corrected for fetal weight. Similarly, in the present study,
high umbilical venous flow [14], correspondingly low placental impedance [36] and increased
portal blood flow permit an up-regulation of liver flow before 30 gestational weeks (Table 3,
Figs 2–5). In contrast, after 30 weeks gestation, fetuses of diabetic mothers had reduced portal
and total venous liver flow when normalized for fetal weight, while in non-diabetic macroso-
mic fetuses no restriction in venous blood flow to the liver was observed (Table 3, Fig 7).
It is known that during placental compromise associated with fetal growth restriction,
shunting through the ductus venosus is prioritized at the expense of the umbilical venous liver
flow [37, 38]. This leads to reduced liver size that increasingly depends on the low-oxygenated
portal flow. In PGDM pregnancies however, the increased risk of chronic hypoxemia, acidosis,
and perinatal death in the last weeks of gestation [39–41] follows relatively greater umbilical
supply during the 2nd trimester (Table 3). The liver received umbilical blood at the expense of
flow through the ductus venosus [14]. Towards the end of pregnancy, PGDM fetuses outgrew
their supply of umbilical venous blood and did not maintain portal flow corresponding to
Fig 7. Fetal venous liver flow development in pregnancies with low risk, macrosomia and PGDM. The fetal venous liver
flow in three different populations: a low-risk population (physiological venous liver flow during the last weeks of pregnancy;
dotted lines), fetal macrosomic growth without maternal diabetes, and pregnancies with pregestational diabetes mellitus
(PGDM, the present study population).
https://doi.org/10.1371/journal.pone.0211788.g007
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their weight (Figs 2 and 3). Although being at risk of relative hypoxia, the re-distribution
mechanisms well-known in fetal growth restriction did not seem to operate.
The strengths of this study are its prospective longitudinal design, involving an unselected
group of PGDM pregnancies, and identical and validated ultrasound and Doppler methods
applied to the reference population [42]. Low intra- and inter-observer variation has been
demonstrated for measurements of ductus venosus flow velocities [43], and almost identical
results for umbilical venous flow were achieved by different investigators using the same tech-
nique for ultrasound measurement and blood flow calculation [26, 44, 45]. The success rate for
measurements varied from 93.4% for left portal vein blood velocity to 52.5% for portal venous
flow, the latter being lower than in the reference population [26]. This was mainly due to diffi-
cult examination conditions caused by high BMI in our study group. Although there was no
inter-group difference in liver flow between PGDM participants with BMI< or�30, a selec-
tion bias cannot entirely be ruled out. Because the BMI was borderline significantly higher in
the missing compared with the complete data group (tested by independent sample t-test,
mean BMI z-score in the QUV liver missing data vs. non-missing data groups were 1.47 and
1.13 respectively, p = 0.07) this could introduce selection of a leaner PGDM population for the
estimation of umbilical venous liver flow. However, such a selection is expected to reduce
rather than augment the differences between the study- and the reference populations. Also,
wider confidence intervals in the study group compared with the reference group warrant a
cautious interpretation of the findings.
Including women with type 1 and type 2 DM in one study group may represent a limita-
tion, since these conditions differ in many respects. Our goal was however, to study fetal flow
and growth in pregnancies with PGDM. Our population was not large enough to answer the
question of whether fetal venous liver circulation is different in pregnancies with type 1 or type
2 DM. Nevertheless, when women with type 2 DM were excluded the findings remained sig-
nificant in the type 1 DM group (S1 Table).
Conclusion
Maternal diabetes is associated with adverse consequences in the offspring [46], including
macrosomia and metabolic syndrome [47], but the underlying mechanisms are not estab-
lished. Fetal liver blood flow is linked to fetal growth, and we showed that flow is related to
maternal blood glucose in the first trimester in PGDM pregnancies. However, the relatively
greater liver perfusion in PGDM pregnancies before 30 weeks was not maintained in late ges-
tation, possibly leading to mismatch between fetal growth and nutrient supply, and later effects
on health.
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